A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more than 20 years.

BMO Capital analyst Evan Seigerman raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $545 from $520 and keeps an Outperform ...

Oracle’s announcement comes after the company’s chairman, Larry Ellison, joined OpenAI CEO Sam Altman and SoftBank CEO Masayoshi Son to announce their joint Stargate Project, which seeks to spend as ...

(NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today released the findings of their 2024 U.S. state and local End-of-Year Rates and Rules Report. It ...

Attentive.ai, a leading AI-based SaaS startup, today announced the successful close of its Series A2 funding round, ...

Google might have just invested another billion dollars into Anthropic, who is one of the main rivals of OpenAI.

Despite the economic uncertainties, healthcare analytics companies have demonstrated strong resilience throughout 2024. The global healthcare analytics industry market size is estimated to grow from ...

The X Games is taking a leap into the digital future by partnering with Google on a new AI judging technology for some ski ...

2025 has kicked off with even more Nintendo Switch 2 leaks, although this time they’re accompanied by a fresh patent that suggests the console includes exciting new tech. Let’s start with the ...